Company intelligence / Profile preview

CPR Therapeutics

Putney, Vermont, United Statescprtherapeutics.com ↗

Ownership: Private
Development stage: Preclinical

Overview

CPR Therapeutics Inc. is developing a next-generation automated mechanical cardiopulmonary resuscitation (CPR) device using a multimodal approach. The company has received NIH and NSF funding and has been awarded multiple patents for its innovations. No clinical trial results have been published yet; the company remains in early-stage R&D focused on improving survival rates from sudden cardiac arrest by surpassing the efficacy of manual chest compressions.

Therapeutic areas: Cardiovascular
Modalities: DeviceNon-pharmacological therapy (Automated mechanical cardiopulmonary resuscitation device)
Industry: Therapeutic Medical Devices

Partnerships

National Institutes of Health (NIH)National Science Foundation (NSF)

Beyond the preview

Go deeper on CPR Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CPR Therapeutics.

Explore the full profile